Title |
Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis
|
---|---|
Published in |
Respiratory Research, April 2014
|
DOI | 10.1186/1465-9921-15-41 |
Pubmed ID | |
Authors |
Tavs Qvist, Tania Pressler, Niels Høiby, Terese L Katzenstein |
Abstract |
Important paradigms of pulmonary disease with nontuberculous mycobacteria (NTM) are currently shifting based on an increasing attention within the field of cystic fibrosis (CF). These shifts are likely to benefit the management of all patients with pulmonary NTM, regardless of underlying pathology. Currently several key areas are being revised: The first outbreak of human NTM transmission has been proven and new evidence of biofilm growth in vivo has been demonstrated. A better understanding of the clinical impact of NTM infection has led to increased diagnostic vigilance and new recommendations for lung transplantation are under way. While recent changes have reinvigorated the interest in NTM disease, the challenge remains, whether such advances can be successfully translated into improved management and care. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 67% |
Spain | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Denmark | 1 | 1% |
Unknown | 85 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 16 | 19% |
Student > Ph. D. Student | 13 | 15% |
Researcher | 11 | 13% |
Student > Bachelor | 10 | 12% |
Student > Doctoral Student | 7 | 8% |
Other | 12 | 14% |
Unknown | 17 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 24% |
Immunology and Microbiology | 15 | 17% |
Agricultural and Biological Sciences | 12 | 14% |
Biochemistry, Genetics and Molecular Biology | 8 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
Other | 4 | 5% |
Unknown | 22 | 26% |